21.27

1.43% 0.30

Pre-market: 21.38 0.11 +0.52%

Catalyst Pharmaceuticals Inc (CPRX)

Overview News Price History Option Chain Financials Why CPRX Down? Discussions Forecast

Catalyst Pharmaceuticals Inc stock is traded at $21.27, with a volume of 959.85K. It is up +1.43% in the last 24 hours and up +7.97% over the past month. Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

Previous Close:

$20.97

Open:

$20.87

24h Volume:

959.85K

Relative Volume:

0.66

Market Cap:

$2.60B

Revenue:

$460.48M

Net Income/Loss:

$142.80M

P/E Ratio:

18.03

EPS:

1.18

Net Cash Flow:

$221.79M

1W Performance:

+1.48%

1M Performance:

+7.97%

6M Performance:

-12.43%

1Y Performance:

-2.43%

1-Day Range:

$20.72

$21.39

1-Week Range:

$20.72

$21.52

52-Week Range:

$19.05

$26.58

Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile

Name

Catalyst Pharmaceuticals Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(305) 529-2522

Address

355 ALHAMBRA CIRCLE, CORAL GABLES

Employee

167

Twitter

@CatalystForRare

Next Earnings Date

2024-11-06

Latest SEC Filings

CPRX's Discussions on Twitter

Compare CPRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPRX Catalyst Pharmaceuticals Inc	21.27	2.57B	460.48M	142.80M	221.79M	1.18
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-04-25	Initiated	Robert W. Baird	Outperform
Nov-18-24	Initiated	Stephens	Overweight
Mar-14-24	Initiated	Citigroup	Buy
Mar-07-24	Initiated	BofA Securities	Buy
Dec-21-23	Initiated	Oppenheimer	Outperform
Aug-24-22	Downgrade	ROTH Capital	Buy → Neutral
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight
Sep-07-18	Resumed	Piper Jaffray	Overweight
Oct-05-16	Upgrade	Piper Jaffray	Neutral → Overweight
Apr-26-16	Downgrade	Piper Jaffray	Overweight → Neutral
Sep-30-14	Reiterated	ROTH Capital	Buy
Sep-16-14	Reiterated	ROTH Capital	Buy
Sep-15-14	Reiterated	H.C. Wainwright	Buy
Oct-21-13	Reiterated	Aegis Capital	Buy
Sep-24-13	Initiated	Maxim Group	Buy
Sep-06-13	Reiterated	Aegis Capital	Buy
Apr-18-13	Initiated	Aegis Capital	Buy
Aug-27-12	Upgrade	Rodman & Renshaw	Mkt Perform → Mkt Outperform
Oct-01-09	Upgrade	Merriman	Sell → Neutral
May-29-09	Downgrade	Hapoalim	Neutral → Underperform
May-29-09	Downgrade	Merriman Curhan Ford	Buy → Sell
Dec-15-08	Initiated	Merriman Curhan Ford	Buy
Nov-28-07	Initiated	Rodman & Renshaw	Mkt Outperform
Jan-31-07	Initiated	Stifel Nicolaus	Buy
Jan-05-07	Initiated	First Albany	Buy

View All

Catalyst Pharmaceuticals Inc Stock (CPRX) Latest News

01:59 AM

Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weaknessGlobal Markets & Reliable Intraday Trade Plans - newser.com

01:59 AM

01:31 AM

Can Catalyst Pharmaceuticals Inc. hit a new high this monthJuly 2025 Sector Moves & Free Community Supported Trade Ideas - newser.com

01:31 AM

01:23 AM

Published on: 2025-11-03 00:23:45 - newser.com

01:23 AM

01:01 AM

Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesWeekly Loss Report & Consistent Return Investment Signals - newser.com

01:01 AM

Nov 02, 2025

Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com

Nov 02, 2025

What risks investors should watch in Catalyst Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Nov 02, 2025

Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Key Highlights & High Conviction Investment Ideas - newser.com

Nov 02, 2025

Nov 01, 2025

Catalyst Pharmaceuticals Inc. recovery potential after sell off2025 Support & Resistance & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025

Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Earnings Growth Report & Real-Time Volume Analysis - newser.com

Nov 01, 2025

Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.Gap Down & Reliable Price Breakout Signals - newser.com

Nov 01, 2025

Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025